06 Feb 2014, BioSpectrum Bureau , BioSpectrum
Singapore: Fluke Biomedical, manufacturer of biomedical test instruments, has acquired Unfors RaySafe. With this acquisition Fluke Biomedical adds devices for diagnostic x-ray from Unfors RaySafe to its product offering. Fluke Biomedical's goal with this acquisition is to provide healthcare providers, institutions and medical device manufacturers with a complete portfolio of test equipment.
"The fact that our companies share a similar culture is an ideal basis for continuing our excellent relationships with our employees, customers and partners," said Mr Magnus Kristoferson, CEO, Unfors RaySafe.
He also added, "We have experience in highly specialized markets all over the world, we know our business and we can now maximize our competencies. In the past, Unfors RaySafe has attracted the attention of the market not just for the functionality and measurement accuracy of its products, but also for the attractive design and intuitive user interface."
Fluke Biomedical leads the world in the manufacture of biomedical test and simulation products, including electrical safety testers, patient simulators, performance analyzers, and fully integrated and automated performance testing and documentation systems.
"The acquisition of Unfors RaySafe brings to Fluke Biomedical a strong team that has delivered leading innovation to the radiation test and safety markets," said Mr Eric Conley, general manager, Fluke Biomedical. "The combination of Unfors RaySafe and Fluke Biomedical accelerates our ability to provide a broad portfolio of world class test equipment to our customers."